Role of FKBP12.6 in hypoxia- and norepinephrine-induced Ca2+ release and contraction in pulmonary artery myocytes

The cellular and molecular processes underlying the regulation of ryanodine receptor (RyR) Ca 2+ release in smooth muscle cells (SMCs) are incompletely understood. Here we show that FKBP12.6 proteins are expressed in pulmonary artery (PA) smooth muscle and associated with type-2 RyRs (RyR2), but not RyR1, RyR3, or IP 3 receptors (IP 3 Rs) in PA sarcoplasmic reticulum. Application of FK506, which binds to FKBPs and dissociates these proteins from RyRs, induced an increase in [Ca 2+ ] i and Ca 2+ -activated Cl − and K + currents in freshly isolated PASMCs, whereas cyclosporin, an agent known to inhibit calcineurin but not to interact with FKBPs, failed to induce an increase in [Ca 2+ ] i . FK506-induced [Ca 2+ ] i increase was completely blocked by the RyR antagonist ruthenium red and ryanodine, but not the IP 3 R antagonist heparin. Hypoxic Ca 2+ response and hypoxic vasoconstriction were significantly enhanced in FKBP12.6 knockout mouse PASMCs. FK506 or rapamycin pretreatment also enhanced hypoxic increase [Ca 2+ ] i , but did not alter caffeine-induced Ca 2+ release (SR Ca 2+ content) in PASMCs. Norepinephrine-induced Ca 2+ release and force generation were also markedly enhanced in PASMCs from FKBP12.6 null mice. These findings suggest that FKBP12.6 plays an important role in hypoxia- and neurotransmitter-induced Ca 2+ and contractile responses by regulating the activity of RyRs in PASMCs.